KidneyCAN shared on LinkedIn:
“KCRS24 Oral Abstract: Exciting insights from Toni Choueiri on the safety profile of Belzutifan monotherapy in RCC patients! Discover the latest findings on adverse events and management strategies.
Source: KidneyCAN/LinkedIn